Charlène J van der Zijden, Anna Bouwman, Bianca Mostert, Joost J M E Nuyttens, Pieter C van der Sluis, Manon C W Spaander, Jan Willem M Mens, Marjolein Y V Homs, Leni van Doorn, Bas P L Wijnhoven, Sjoerd M Lagarde
Definitive chemoradiotherapy (dCRT) is a potentially curative therapy for esophageal cancer. As indications for dCRT differ widely, it is challenging to draw conclusions on outcomes and survival. The aim of this study was to evaluate overall survival (OS) and recurrence patterns according to indications for treatment. Patients who underwent dCRT (50.4 Gy concomitant with carboplatin/paclitaxel) for esophageal cancer between 2012 and 2022 were identified. Indications for dCRT were: cervical tumor, irresectable disease, unfit for surgery, and patient and/or physician preference...
June 5, 2024: Diseases of the Esophagus: Official Journal of the International Society for Diseases of the Esophagus